ArticleGynecology and pelvic medicine2024
Atezolizumab does not improve progression-free survival in patients with recurrent platinum-sensitive ovarian cancer.
Walter H Gotlieb et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
1 paper cites it
this papercites it